(2E)-3-(3-bromophenyl)-1-(3-methoxyphenyl)prop-2-en-1-one, 95.0%, 2g

Naphthalene-1,5-diol, 95.0%, 500g

N-benzyl-2-chloro-5,6,7,8-tetrahydroquinazolin-4-amine, 95%, 100mg

methyl 2-chloro-2-(4-chlorophenyl)acetate, 95.0%, 1g

3-[3,5-bis(trifluoromethyl)phenyl]-5-chloro-1,2-oxazole-4-carbaldehyde, 95.0%, 2g

(3aS,8aR)-2-(6-Phenylpyridin-2-yl)-8,8a-dihydro-3aH-indeno[1,2-d]oxazole, 97%, 100mg

1-(2-hydroxyethyl)-3,4-dimethylpyrano[2,3-c]pyrazol-6(1H)-one, 95.0%, 1g

(R)-2-Hydroxy-4-methylpentanoic acid, 95.0%, 10g

1-Cyclopropylethanone oxime, 250mg

6-Fluoroisoindolin-1-one, 95.0%, 250mg

tert-butyl 3,9-diazaspiro[5.6]dodecane-3-carboxylate, 95.0%, 5g

Frit réversible 500 ml, 3 (16 – 40 μm), 1 pièce

NOTOGINSENOSIDE R1, 98%, 5g